Landlord Fights Back After Generation Terminates Waltham Lease
Generation Bio Co., based in Cambridge, seeks to terminate its lease at a Waltham biomanufacturing facility, citing a breach of agreement, reported by Boston Business Journal.
The 104,000-square-foot lease at 41 Seyon St, Waltham, MA., was signed in 2021. The landlord, CS Capital Management, disputes the termination, claiming no breach occurred. CS Capital, who acquired the building from TPG Inc., contests Generation’s right to end the lease.
Generation intends to defend its termination decision. The biotech recently announced significant layoffs, affecting 40% of its workforce, amid its focus on gene therapies. Despite challenges, Generation has collaborated with Moderna Inc. and emphasizes gene therapies beyond liver targets.
Emily Fu is Content Director of Connect Commercial Real Estate, where she covers the east coast markets, including New York, Boston & New England, and DC & Mid-Atlantic markets. She produces daily news stories as well as longer-form content, ranging from Q&As to thought-leadership pieces. She also writes feature stories for Connect Money.
With previous stints at Reuters, Seeking Alpha, and Commercial Observer, Emily has covered the finance side of the commercial real estate industry, technology, media, telecom (TMT), and fashion. She attended the Columbia Graduate School of Journalism and currently resides in Manhattan.